CellaVision AB (publ)
CLVSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $723,217 | $677,292 | $639,340 | $565,552 |
| % Growth | 6.8% | 5.9% | 13% | – |
| Cost of Goods Sold | $236,143 | $214,251 | $201,023 | $173,250 |
| Gross Profit | $487,074 | $463,041 | $438,317 | $392,302 |
| % Margin | 67.3% | 68.4% | 68.6% | 69.4% |
| R&D Expenses | $87,447 | $83,333 | $88,553 | $64,248 |
| G&A Expenses | $85,357 | $76,032 | $73,536 | $63,077 |
| SG&A Expenses | $221,949 | $212,656 | $191,498 | $165,323 |
| Sales & Mktg Exp. | $136,592 | $136,624 | $117,962 | $102,246 |
| Other Operating Expenses | -$1 | $1 | $0 | -$2 |
| Operating Expenses | $309,395 | $295,990 | $280,051 | $229,569 |
| Operating Income | $177,679 | $167,051 | $158,266 | $162,733 |
| % Margin | 24.6% | 24.7% | 24.8% | 28.8% |
| Other Income/Exp. Net | -$819 | -$2,829 | -$9,837 | -$4,436 |
| Pre-Tax Income | $176,860 | $164,222 | $148,429 | $158,297 |
| Tax Expense | $36,138 | $33,913 | $30,094 | $32,958 |
| Net Income | $140,722 | $130,309 | $118,335 | $125,339 |
| % Margin | 19.5% | 19.2% | 18.5% | 22.2% |
| EPS | 5.9 | 5.46 | 4.96 | 5.25 |
| % Growth | 8.1% | 10.1% | -5.5% | – |
| EPS Diluted | 5.9 | 5.46 | 4.96 | 5.25 |
| Weighted Avg Shares Out | 23,852 | 23,852 | 23,852 | 23,852 |
| Weighted Avg Shares Out Dil | 23,852 | 23,852 | 23,852 | 23,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,127 | $898 | $200 | $60 |
| Interest Expense | $1,886 | $3,260 | $2,340 | $1,866 |
| Depreciation & Amortization | $41,005 | $39,763 | $40,097 | $33,437 |
| EBITDA | $219,751 | $207,245 | $190,866 | $193,600 |
| % Margin | 30.4% | 30.6% | 29.9% | 34.2% |